Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Evan Levine currently holds 84,723,778 shares of ADVENTRX PHARMACEUTICALS INC (ANX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Evan Levine has been a net buyer of ANX stock. They have purchased $4.0M and sold $729.2K worth of shares.
Evan Levine's most recent insider trade was on Nov 30, 2018, when they sold 77,777,778 shares at $0.00 per share.
Evan Levine serves as Executive at ADVENTRX PHARMACEUTICALS INC (ANX). They have executed 52 insider transactions totaling $4.7M over their tenure at the company.
Evan Levine holds the position of Executive at ADVENTRX PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 22 years and currently hold a stake valued at $0.
Evan Levine has shown a buying trading pattern, with $4.0M in total purchases and $729.2K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Evan Levine was on Nov 8, 2016, when they purchased $3.9M worth of PBYA shares. This transaction involved 4,928,046 shares at $0.80 per share.
Evan Levine currently owns 84,723,778 shares of ADVENTRX PHARMACEUTICALS INC (ANX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Evan Levine's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Evan Levine has 52 Form 4 filings on record as an insider at ADVENTRX PHARMACEUTICALS INC.
Set alerts for Evan Levine and 40,000+ other insiders.